Kepler Capital Markets advice for Biotest
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| March 31, 2017 | Kepler Capital Markets | Biotest | Buy | 16.50 EUR | -63.33 % |
Advice details
Op 31 Mar 2017 herhalen de analisten van Kepler Capital Markets hun koopadvies voor Biotest (ISIN: DE0005227235 / Mnemo: BIO). Het 12-maands koersdoel blijft gehandhaafd op 16.5 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 